Oncostatin M induces dendritic cell maturation and Th1 polarization

Biochemical and Biophysical Research Communications

Volumn 394, Issue 2, 2010, Pages 272-278

  Jung, In Duk ^a   Noh, Kyung Tae ^a   Lee, Chang Min ^a   Chun, Sung Hak ^a   Jeong, Soo Kyung ^a   Park, Jin Wook ^a   Park, Won Sun ^b   Kim, Han Wool ^c   Yun, Cheol Heui ^c   Shin, Yong Kyoo ^d   Park, Yeong Min ^a  

^a National Research Laboratory of Dendritic Cell Differentiation and Regulation   (South Korea)

^b Kangwon National University   (South Korea)

^c Seoul National University   (South Korea)

^d Chung Ang University   (South Korea)

Author keywords

Dendritic cells; MAPKs; NF B; Oncostatin M; Th1 polarization

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE; ONCOSTATIN M;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; ENDOCYTOSIS; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MALE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL;

ACTIVE TRANSPORT, CELL NUCLEUS; ADAPTIVE IMMUNITY; ANIMALS; DENDRITIC CELLS; ENZYME ACTIVATION; IMMUNITY, INNATE; INTERLEUKIN-10; INTERLEUKIN-12; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NF-KAPPA B; ONCOSTATIN M; ONCOSTATIN M RECEPTOR BETA SUBUNIT; TH1 CELLS;

EID: 77950270381     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.02.153     Document Type: Article

References (24)

1. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., and Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18 (2000) 767-811
2. Young L.J., Wilson N.S., Schnorrer P., Mount A., Lundie R.J., La Gruta N.L., Crabb B.S., Belz G.T., Heath W.R., and Villadangos J.A. Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens. Proc. Natl. Acad. Sci. USA 104 (2007) 17753-17758
3. Csomor E., Bajtay Z., Sandor N., Kristof K., Arlaud G.J., Thiel S., and Erdei A. Complement protein C1q induces maturation of human dendritic cells. Mol. Immunol. 44 (2007) 3389-3397
4. Kapsenberg M.L. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 3 (2003) 984-993
5. Zitvogel L., Terme M., Borg C., and Trinchieri G. Dendritic cell-NK cell cross-talk: regulation and physiopathology. Curr. Top. Microbiol. Immunol. 298 (2006) 157-174
6. Grove R.I., Mazzucco C.E., Radka S.F., Shoyab M., and Kiener P.A. Oncostatin M up-regulates low density lipoprotein receptors in HepG2 cells by a novel mechanism. J. Biol. Chem. 266 (1991) 18194-18199
7. Zarling J.M., Shoyab M., Marquardt H., Hanson M.B., Lioubin M.N., and Todaro G.J. Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells. Proc. Natl. Acad. Sci. USA 83 (1986) 9739-9743
8. Tanaka M., and Miyajima A. Oncostatin M, a multifunctional cytokine. Rev. Physiol. Biochem. Pharmacol. 149 (2003) 39-52
9. Diveu C., Lelievre E., Perret D., Lak-Hal A.H., Froger J., Guillet C., Chevalier S., Rousseau F., Wesa A., Preisser L., Chabbert M., Gauchat J.F., Galy A., Gascan H., and Morel A. GPL, a novel cytokine receptor related to GP130 and leukemia inhibitory factor receptor. J. Biol. Chem. 278 (2003) 49850-49859
10. Wang Y.D., Gu Z.J., Huang J.A., Zhu Y.B., Zhou Z.H., Xie W., Xu Y., Qiu Y.H., and Zhang X.G. gp130-linked signal transduction promotes the differentiation and maturation of dendritic cells. Int. Immunol. 14 (2002) 599-603
11. Mosley B., De Imus C., Friend D., Boiani N., Thoma B., Park L.S., and Cosman D. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J. Biol. Chem. 271 (1996) 32635-32643
12. Tanaka M., Hara T., Copeland N.G., Gilbert D.J., Jenkins N.A., and Miyajima A. Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor beta subunit. Blood 93 (1999) 804-815
13. de Jong E.C., Smits H.H., and Kapsenberg M.L. Dendritic cell-mediated T cell polarization. Springer Semin. Immunopathol. 26 (2005) 289-307
14. Langrish C.L., McKenzie B.S., Wilson N.J., de Waal Malefyt R., Kastelein R.A., and Cua D.J. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 202 (2004) 96-105
15. An H., Yu Y., Zhang M., Xu H., Qi R., Yan X., Liu S., Wang W., Guo Z., Guo J., Qin Z., and Cao X. Involvement of ERK, p38 and NF-κB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells. Immunology 106 (2002) 38-45
16. Rescigno M., Martino M., Sutherland C.L., Gold M.R., and Ricciardi-Castagnoli P. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med. 188 (1998) 2175-2180
17. Sugaya M., Fang L., Cardones A.R., Kakinuma T., Jaber S.H., Blauvelt A., and Hwang S.T. Oncostatin M enhances CCL21 expression by microvascular endothelial cells and increases the efficiency of dendritic cell trafficking to lymph nodes. J. Immunol. 177 (2006) 7665-7672
18. Wang Y., Robledo O., Kinzie E., Blanchard F., Richards C., Miyajima A., and Baumann H. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor. J. Biol. Chem. 275 (2000) 25273-25285
19. Nishibe T., Parry G., Ishida A., Aziz S., Murray J., Patel Y., Rahman S., Strand K., Saito K., Saito Y., Hammond W.P., Savidge G.F., Mackman N., and Wijelath E.S. Oncostatin M promotes biphasic tissue factor expression in smooth muscle cells: evidence for Erk-1/2 activation. Blood 97 (2001) 692-699
20. Akira S. Toll-like receptor signaling. J. Biol. Chem. 278 (2003) 38105-38108
21. Clegg C.H., Rulffes J.T., Wallace P.M., and Haugen H.S. Regulation of an extrathymic T-cell development pathway by oncostatin M. Nature 384 (1996) 261-263
22. Esashi E., Ito H., Minehata K., Saito S., Morikawa Y., and Miyajima A. Oncostatin M deficiency leads to thymic hypoplasia, accumulation of apoptotic thymocytes and glomerulonephritis. Eur. J. Immunol. 39 (2009) 1664-1670
23. Suda T., Chida K., Todate A., Ide K., Asada K., Nakamura Y., Suzuki K., Kuwata H., and Nakamura H. Oncostatin M production by human dendritic cells in response to bacterial products. Cytokine 17 (2002) 335-340
24. Park S.J., Nakagawa T., Kitamura H., Atsumi T., Kamon H., Sawa S., Kamimura D., Veda N., Iwakura Y., Ishihara K., Murakami M., and Hirano T. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J. Immunol. 173 (2004) 3844-3854